Cuba increases production of Itolizumab against Covid-19
Havana, Sep 2.- A production campaign of Itolizumab, a monoclonal antibody used as a treatment for serious Covid-19 cases was recently completed, informed authorities of the Center for Molecular Immunology (CIM) of Cuba.
Read More